Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michal Budinský"'
Publikováno v:
Chemické listy. 116:746-750
The radiopharmaceutical 68Ga-PSMA-11 represents a radiopharmaceutical drug without marketing authorization for the prostate cancer diagnosis in a specific treatment program. In respect of the radiopharmaceutical technology, the difficultness of the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44dd8815855f256b0dc9bbb9c889949f
https://doi.org/10.54779/chl20220746
https://doi.org/10.54779/chl20220746
Autor:
Michal Budinský, Janka Petrovičová
Publikováno v:
Proceedings of CBU in Economics and Business. 1:30-36
The implementation of new technologies among businesses is a common practice, in order to keep their market position and to enhance their performance. As the world changes further, high-tech innovations and applications take place. Notably, biometric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71100b3653c56dd2e67aa3afdc740381
https://doi.org/10.12955/peb.v1.14
https://doi.org/10.12955/peb.v1.14
Autor:
Michal Budinský, Petr Vyšinský, Stanislav Synek, Beatrix Bencsiková, Iveta Selingerová, Zdeněk Řehák
Publikováno v:
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti. 70(4)
The radiopharmaceutical 68Ga-DOTATOC represents the latest radiopharmaceutical in the diagnosis of a neuroendocrine tumor with somatostatin receptor overexpression. Technological and economic difficulties of preparing and quality control of the radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb7d509f261a43f2e09b00a039dac7d
https://pubmed.ncbi.nlm.nih.gov/35045714
https://pubmed.ncbi.nlm.nih.gov/35045714
Autor:
Michal Budinský, Jiří Vašina, Pavel Šlampa, Tomáš Novotný, Zdeněk Řehák, Petr Dvořáček, Marek Slávik
Publikováno v:
Klinicka onkologie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5de4fa6c1d352c047cbb620160cba87
https://doi.org/10.48095/ccko2021241
https://doi.org/10.48095/ccko2021241
Publikováno v:
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti. 69(5-6)
Preparation of radiopharmaceuticals means everyday exposure to ionizing radiation for pharmaceutical workers. Manual preparation of positron radio-pharmaceuticals may be a risk in exceeding the legisla-tive limits for radiation workers, in particular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28ebbd0c70d776bf826f4bcf537d35a4
https://pubmed.ncbi.nlm.nih.gov/33736447
https://pubmed.ncbi.nlm.nih.gov/33736447
Publikováno v:
Advances in Longitudinal Data Methods in Applied Economic Research ISBN: 9783030639693
Increase in the requirement of still more demanding customers forces businesses to improve their processes, especially in meeting their needs with the highest efficiency. In order to reach this aim, one of the possibilities is utilization of new tech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1213ff1a9a6e4edb636d0be994fe03bb
https://doi.org/10.1007/978-3-030-63970-9_10
https://doi.org/10.1007/978-3-030-63970-9_10
Publikováno v:
Hidden Champions in Dynamically Changing Societies ISBN: 9783030654504
Hidden champions (HC) originally defined by Herman Simon as globally or regionally highly successful companies with specific features have been revealed and studied also in the Slovak context. Based on in-depth interviews with CEO Representatives and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e5272674252ffe2980605a0a8a4fc93
https://doi.org/10.1007/978-3-030-65451-1_25
https://doi.org/10.1007/978-3-030-65451-1_25